The Women's Bible Study classes will resume on Sept. 16. There are two classes to choose from every Tuesday -- 9:15-11:15 a.m ...

The Company plans to use the proceeds to accelerate the development of Teverelix, a next generation GnRH Antagonist, as a ...

Most medical schools teach students about illness through lectures or clinical vignettes as taught by doctors, but Boston ...

Topline data were announced from a phase 3 trial evaluating efzofitimod in patients with pulmonary sarcoidosis.

Absci is developing ABS-101, an anti-TL1A antibody with potential in ulcerative colitis, Crohn's disease, and other ...

Sacubitril/valsartan shows evidence of benefit in the first randomized trial evaluating a drug treatment for patients with ...

FBI Director Kash Patel condemned political violence from both the left and the right during questioning on Capitol Hill.

A new study has found "strong causal evidence" that banning phones improves results in the classroom - and a local principal ...

Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; ...

In a milestone for Southeast Asia's healthcare sector, Singapore's Ministry of Health (MOH), MOH Holdings Pte Ltd (MOHH), and the Centre for ...

There could be a 90 percent chance that in the next decade, astronomers will spot a deep space explosion that confirms ...

Ozempic® is the only GLP-1 RA that has proven risk reduction of cardiovascular and kidney events in people with type 2 diabetes3-6. These results provide the first direct comparison of cardiovascular ...